Medicare Enrolled

Dr. Adebambo Ojuri, M.D.

Optician · Los Angeles, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Mixed engagement
8110 AIRPORT BLVD, Los Angeles, CA 90045
3106740144
In practice since 2006 (19 years)
NPI: 1679644983 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ojuri from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ojuri? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ojuri

Dr. Adebambo Ojuri is an optician specialist in Los Angeles, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ojuri performed 626 Medicare services across 591 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ojuri received a total of $89,614 from 30 pharmaceutical and/or device companies across 499 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Payments are distributed across multiple categories and often reflect legitimate professional engagement with the medical industry. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ojuri is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 626 Medicare services $89,614 industry payments

Medicare Practice Summary

Medicare Utilization ↗
626
Medicare services
Bottom 36% in CA for optician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
591
Unique beneficiaries
$74
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~33 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Moderate sedation during GI endoscopy
Sedation services provided by the physician performing a gastrointestinal endoscopic procedure. This requires an independent trained observer to assist in monitoring the patient.
210 $4 $132
Colonoscopy with biopsy
A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease.
112 $117 $848
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
92 $108 $515
Upper GI endoscopy with biopsy
A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities.
89 $84 $700
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
87 $87 $337
Colon polyp removal with endoscopic snare
This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination.
36 $201 $996
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$89,614
Total received (2018-2024)
Avg $12,802/year across 7 years
Top 4% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
499
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Other
Charitable contributions, space rental, and other categories
$74,784 (83.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,038 (9.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,781 (7.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$11 (0.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$75,811
2023
$768
2022
$1,665
2021
$1,604
2020
$1,051
2019
$1,053
2018
$7,662

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Olympus America Inc.
$74,784
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$309
PFIZER INC.
$170
Merck Sharp & Dohme LLC
$112
RedHill Biopharma Inc.
$82
ABBVIE INC.
$79
Takeda Pharmaceuticals U.S.A., Inc.
$74
Gilead Sciences, Inc.
$68
Ardelyx, Inc.
$45
Madrigal Pharmaceuticals
$36
Alcresta Therapeutics, Inc.
$22
Celltrion USA Inc.
$17
Braintree Laboratories, Inc.
$14
Top 3 companies account for 99.3% of 2024 payments
All-time payments by company (2018-2024) ›
Olympus America Inc.
$74,784
PFIZER INC.
$6,985
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,867
AbbVie Inc.
$1,172
ABBVIE INC.
$1,040
Gilead Sciences, Inc.
$979
AbbVie, Inc.
$555
RedHill Biopharma Inc.
$551
Merck Sharp & Dohme LLC
$350
Allergan Inc.
$342
Takeda Pharmaceuticals U.S.A., Inc.
$309
QOL Medical, LLC
$89
Merck Sharp & Dohme Corporation
$81
PENTAX of America, Inc.
$62
Janssen Biotech, Inc.
$55
Allergan, Inc.
$51
Ardelyx, Inc.
$45
Madrigal Pharmaceuticals
$36
Ethicon US, LLC
$32
Boston Scientific Corporation
$30
TerSera Therapeutics LLC
$27
Ferring Pharmaceuticals Inc.
$24
Celgene Corporation
$24
Alcresta Therapeutics, Inc.
$22
Medtronic, Inc.
$20
BOSTON SCIENTIFIC CORPORATION
$19
Vertiflex, Inc.
$17
Celltrion USA Inc.
$17
Intercept Pharmaceuticals, Inc.
$16
Braintree Laboratories, Inc.
$14
Top 3 companies account for 93.3% of all-time payments
Associated products mentioned in payments ›
APRISO · Aemcolo · C2 CryoBalloon · CLENPIQ · CRE · CREON · Creon · DIFICID · ENTYVIO · Entyvio · GASTROINTESTINAL VIDEOSCOPE · GATTEX · GI Genius · HUMIRA · Humira · IBSRELA · INFLECTRA · LINX Reflux Management System · LINZESS · MAVYRET · MOTEGRITY · Mavyret · Movantik · OCALIVA · PLENVU · RELIZORB · REMICADE · RESMETIROM · RINVOQ · SKYRIZI · STELARA · SUFLAVE · Sucraid · Superion ISS · TRULANCE · Talicia · UCERIS TABLETS · VEGZELMA · VIBERZI · XELJANZ · XIFAXAN · XIFAXANIBSD · Xermelo · ZENPEP · ZEPATIER · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Payments are distributed across multiple categories with no single dominant type. Total industry engagement is in the top 4% for optician in CA.

Looking for an optician specialist in Los Angeles?
Compare opticians in the Los Angeles area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
1,538
Per 100K population
15.6
County median income
$87,760
Nearest hospital
CEDAR-SINAI MARINA DEL REY HOSPITAL
3.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Ojuri is a clinical cardiology specialist, with moderate Medicare volume, with mixed engagement industry engagement in the top 4% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Ojuri experienced with moderate sedation during gi endoscopy?
Based on Medicare claims data, Dr. Ojuri performed 210 moderate sedation during gi endoscopy services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ojuri receive payments from pharmaceutical companies?
Yes. Dr. Ojuri received a total of $89,614 from 30 companies across 499 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ojuri's costs compare to other opticians in Los Angeles?
Dr. Ojuri's average Medicare payment per service is $74. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ojuri) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →